Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
Crossref DOI link: https://doi.org/10.1007/s13300-019-00746-4
Published Online: 2020-01-03
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hidvégi, Tibor
Balogh, Zoltán
Vass, Viktor
Kovács, Gábor
Stella, Péter
Funding for this research was provided by:
Sanofi Hungary
Article History
Received: 12 November 2019
First Online: 3 January 2020